A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma

British Journal of Cancer, Published online: 24 February 2021; doi:10.1038/s41416-021-01259-3A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma

Source: British Journal of Cancer - February 24, 2021 Category: Cancer & Oncology Authors: Chris Twelves Michael Sabel Daniel Checketts Sharon Miller Bola Tayo Maria Jove Lucy Brazil Susan C. Short Catherine McBain Brian Haylock Paul Mulholland Christopher Herbert Allan James Mohan Hingorani Joerg Berrouschot Rainer Fietkau Jens Panse Source Type: research